Coverage
Filings
Orion's collaboration partner Bayer announced U.S. FDA approval for darolutamide, an androgen receptor inhibitor (ARi), for metastatic hormone-sensitive prostate cancer (mHSPC).
| 9 Feb 2006 |
| Matters to be handled at Orion?s AGM on 21 March 2006 | 9 Feb 2006 |
| Recommendation by the nomination committee concerning Boards of Directors to be elected by the AGM | 30 Jan 2006 |
| Orion appoints Kimmo Virtanen CFO of the Wholesale and Distribution Division | 27 Jan 2006 |
| Orion updates information about Abbott's progress with Simdax | 26 Jan 2006 |